Clinical trial
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of…
NCT00400439 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00400439 |
|---|---|
| Title | A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381 |
| Official title | A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381 |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Heart Disease |
| Intervention type | Drug |
| Interventions | dalcetrapib (RO4607381), placebo |
| Enrollment | 77 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Nov 16, 2006 |
| Last update posted | Jan 3, 2020 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: